Occupe actuellement des postes chez Aurinia Pharmaceuticals Inc, Ionis Pharmaceuticals Inc and Xenon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Aurinia Pharmaceuticals Inc | 22 février 2018 - |
Director | Ionis Pharmaceuticals Inc | 24 septembre 2018 - |
Independent Director | Xenon Pharmaceuticals Inc | 1 janvier 1996 - |
President - Global Research and Development, Chief Scientific Officer | Teva Pharmaceutical Industries Ltd | 8 mai 2012 - 31 décembre 2017 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-09-26 | 2023-09-22 |
Abcellera Biologics Inc
(ABCL)
|
A Achat |
20 000
+1.5%
4,9198 200 USD |
20 000 +1.5% | 4,91 | 98 200 USD | |
2023-08-09 | 2023-08-08 |
Abcellera Biologics Inc
(ABCL)
|
A Achat |
30 000
+2.4%
5,90177 000 USD |
30 000 +2.4% | 5,90 | 177 000 USD | |
2023-03-30 | 2023-03-28 |
89Bio Inc
(ETNB)
|
A Achat |
61 538
+inf%
16,15993 839 USD |
61 538 +inf% | 16,15 | 993 839 USD | |
2023-03-30 | 2022-04-07 |
89Bio Inc
(ETNB)
|
A Achat |
10 000
+11.9%
3,4834 750 USD |
10 000 +11.9% | 3,48 | 34 750 USD | |
2023-03-30 | 2022-03-30 |
89Bio Inc
(ETNB)
|
A Achat |
6 250
+8.0%
3,6222 625 USD |
6 250 +8.0% | 3,62 | 22 625 USD | |
2021-06-22 | 2021-06-22 |
Abcellera Biologics Inc
(ABCL)
|
V Vente |
100 000
-9.1%
25,502 550 000 USD |
100 000 -9.1% | 25,50 | 2 550 000 USD | |
2020-12-17 | 2020-12-15 |
Abcellera Biologics Inc
(ABCL)
|
A Achat |
73 665
+165.2%
20,001 473 300 USD |
73 665 +165.2% | 20,00 | 1 473 300 USD |